Lab Coat Ceremony for PhD and MD/PhD Students Marks the Start of New Journeys in Research and Training

Amid cheers and applause, first-year PhD students and third-year MD/PhD students received crisp white lab coats to mark the start of their journeys into academic research and training during a recent ceremony held by the Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai. The lab coats symbolize the professionalism and authority that trainees will develop and nurture during their time at Mount Sinai.

“Our PhD programs in biomedical sciences, neuroscience, and clinical research provide rigorous collaborative training that prepares our students to spearhead the next generation of scientific and medical breakthroughs,” said Marta Filizola, PhD, Dean of the Graduate School of Biomedical Sciences and the Sharon & Frederick A. Klingenstein-Nathan G. Kase, MD Professor as she welcomed the students, faculty, and guests.

Marta Filizola, PhD

Today’s biomedical and clinical research efforts, she said, must help “solve complex problems and find solutions grounded in data and their rigorous statistical analysis. We are branching out into new realms of research that leverage artificial intelligence and other emerging technologies in medicine to improve patient health and quality of life. Our students are a crucial part of this growth.” Dr. Filizola is also Professor of Pharmacological Sciences, Neuroscience, and Artificial Intelligence and Human Health.

Eric J. Nestler, MD, PhD, Dean for Academic Affairs at Icahn Mount Sinai, and Chief Scientific Officer for the Mount Sinai Health System told the students: “We want you to aim high…Don’t settle on a project because it’s easy and doable. Instead, take a chance by studying something that in its own small way will change the world.”

Why a PhD in Biomedical Sciences? Click here to read how student Mount Sinai lnspired student Ashley Richardson to study immunology and microbiology.

Dr. Nestler said, “I’ve given a lot of thought over the years to what constitutes the essential ingredients for such an undertaking. First, is novelty. Dr. Albert Einstein once said, ‘If you do what you always did, you will get what you always got.’” He also mentioned relevance of the work, technical innovation, creativity, collaboration, perseverance—and “having an available and generous principal investigator and other members of your lab who can also help with brainstorming, troubleshooting, and collaborative experiments [and who] should also support your goals of thinking big, having big expectations for yourself, and publishing your work as high-impact papers in respected, peer-reviewed journals.” Dr. Nestler is also Director of The Friedman Brain Institute and Nash Family Professor of Neuroscience at Icahn Mount Sinai.

Eric J. Nestler, MD, PhD

Genomic scientist Brynn Levy, M.Sc.(Med), PhD, FACMG, who received his PhD degree in clinical cytogenetics from Mount Sinai in 1999 and is world-renowned in the clinical utility of genomic technologies in reproductive medicine, gave an insightful speech about his own educational journey and experiences.

“The first piece of advice I have for you is: be an active participant in your profession, and get involved. As you begin to entrench yourself in your profession, try to be more than just a sideline observer,” he told the students. Also, “It’s important to enjoy what you do” and to “treat every day as a learning experience. Identify great mentors and embrace them, as great mentors teach you more than just medicine and science.”

Dr. Levy is Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center (CUIMC), Medical Director of the Clinical Cytogenetics Laboratory at New York Presbyterian Hospital, and Co-Director of the Laboratory of Personalized Genomic Medicine at CUIMC.

Dr. Levy said that he was fortunate to have “two amazing mentors”—the late Kurt Hirshhorn, MD, at Mount Sinai, and the late Dorothy Warburton, PhD, at Columbia, each a trailblazing researcher in the cytogenetics field.

Dr. Hirshhorn was a legendary pediatrician, medical geneticist, and cytogeneticist known for groundbreaking research during his 50-year career at Mount Sinai, which included establishing one of the first laboratories in the nation for clinical chromosome studies. Among his many honors, he was a member of the National Academy of Medicine. “Kurt led by example,” said Dr. Levy. “Over and above his phenomenal accomplishments and knowledge, he taught me how to have confidence in myself. He never micromanaged me, and instead, he gave me autonomy…He taught me the meaning of paying it forward, possessing the insight of the importance of investing in the next generation.”

Brynn Levy, M.Sc.(Med), PhD, FACMG

Dr. Levy concluded: “As you all embark on the exciting new pathway that you’ve chosen for yourselves, I hope you invest in yourselves. Get involved in your field and engage with your community and colleagues. Be curious and treat every day as a lesson in medicine, science, as well as life. Know your limitations, and see those around you as a resource to continuously improve who you are and what you do. In doing so, I trust that every day will be fulfilling, and you will no doubt make an indelible impact on many patients’ lives and on society as a whole.”

With great fanfare, each student was presented with a lab coat, an effort sponsored annually by the Mount Sinai Alumni Association. Standing together and wearing their lab coats, they recited the PhD Oath in unison. “With my Doctor of Philosophy, I willingly pledge to uphold the highest levels of integrity, professionalism, scholarship, and honor,” they said, as they read a set of guiding principles that would start them on their journeys to rewarding and enjoyable careers.

A slideshow of snapshots from the Lab Coat Ceremony

How Mount Sinai is Using Artificial Intelligence to Improve the Diagnosis of Breast Cancer

Laurie Margolies, MD, a radiologist who is Chief of Breast Imaging at the Dubin Breast Center and Vice Chair, Breast Imaging, Mount Sinai Health System

More and more people are getting mammograms as the population ages, as more younger people are choosing to get screened, and as the benefits of accurate screening and early detection of breast cancer remain clear.

Breast cancer is the most common cancer among women in the United States, except for skin cancer. Each year, about 240,000 cases of breast cancer are diagnosed in women (and about 2,100 in men), according to the U.S. Centers for Disease Control and Prevention.

In response to this growing need, Mount Sinai has expanded its network of breast imaging sites, and  has deployed a new tool: artificial intelligence.

In this Q&A, Laurie Margolies, MD, a radiologist who is Chief of Breast Imaging at the Dubin Breast Center and Vice Chair, Breast Imaging, Mount Sinai Health System, explains how radiologists at the Mount Sinai Breast Cancer of Excellence for Breast Cancer are leveraging the power of artificial intelligence to achieve a more precise diagnosis, which allows surgeons and oncologists to start the right treatment sooner, giving patients the best possible outcome.

How does AI help patients in the diagnosis of breast cancer?

AI is a new tool that gives a second opinion on a mammogram. It assists the radiologist, it does not replace the radiologist. It’s like having a very well trained senior fellow sitting next to you. Multiple studies have shown that when you have radiologists working with AI, you find more breast cancers, and often smaller cancers. What’s great about AI is that it never gets tired, it can’t get distracted. But there’s no substitute for the experience of the radiologist.

How does it help with “call backs”?

This additional review can help radiologists determine instances where there is a very low probability of cancer. This helps to reduce the number of times that patients will be asked to return for another procedure to get a closer look at an area of possible concern, which many know as a “call back.” Fewer than 10 percent of women who are asked to return are typically found to have cancer. But these extra screenings make people anxious, they cost money, and they fill our breast centers with people who don’t need to be there.

How does AI work? What does the patient see?

Patients will not see any difference in the process. As your radiologist is reading your mammogram or sonogram on their computer, they can access a special program that will also review the scan. It takes a few extra minutes. In many cases, AI reviews the scan before the radiologist and highlights areas for the radiologist to pay extra attention.

Who can access this service?

Anyone who receives a mammogram or breast ultrasound performed at Mount Sinai will have access to this AI capability. There is no extra cost to patients.

Congratulations to the 2023 Mount Sinai Emergency Nurse Awardees

The Department of Emergency Medicine at Mount Sinai celebrated the Second Annual Emergency Nurse Awards in recognition of Emergency Nurses Week.

At Mount Sinai, there are more than 700 emergency nursing team members committed to caring for our patients within our Emergency Departments and across the Mount Sinai Health System.

The ceremony, held Tuesday, October 9 in the Hatch Auditorium at The Mount Sinai Hospital, honored 40 emergency nursing team members across seven categories.

Opening remarks by Mount Sinai leadership included Robin Ferrer, MBA, MSN, RN, System Vice President of Emergency Medicine; Beth Oliver, DNP, RN, FAAN, Chief Nurse Executive and Senior Vice President, Cardiac Services; and David Reich, MD, President of The Mount Sinai Hospital and Mount Sinai Queens who spoke about the positivity and optimism displayed every day by emergency nurses.

Afterwards, awardees and their families gathered with fellow team members to celebrate.

Rookie of the Year Award

The recipient for this category has eighteen months or less experience working in the Emergency Department and consistently displays confidence, initiative and high potential in providing clinical care and contributing to the team’s success.

Mount Sinai West: Katherine Schuerger

Mount Sinai Brooklyn: Jennifer Yun

Mount Sinai Queens: Saskia Moore (not pictured)

The Mount Sinai Hospital: Donovan Carey

Mount Sinai Morningside: Xinyue Zheng

Mount Sinai Beth Israel: Nicole Brophy

Mount Sinai South Nassau: Gianni Lise Delgado-Gaines

Preceptor of the Year Award

The recipient for this category serves as a resource and mentor for team members and new hires by sharing knowledge and skills and exemplifying best practices in providing care to our community of patients.

Mount Sinai West: Emma Frankel

Mount Sinai Brooklyn: Valerie Merrell (not pictured)

Mount Sinai Queens: Eric Peterson

The Mount Sinai Hospital: Rachel Miguel

Mount Sinai Morningside: Corine Lamy

Mount Sinai Beth Israel: Hermia Bertrand

Mount Sinai South Nassau: Meghan Evans (not pictured)

Support Staff Member of the Year Award

The recipient for this category demonstrates support of and collaboration with nursing staff through effective teamwork, clear communication, focus on patient safety, and enhancing the overall experience for patients and families.

Mount Sinai West: Vincent Love

Mount Sinai Brooklyn: Gilbert Quiocho (not pictured)

Mount Sinai Queens: Jessica Vicuna (not pictured)

The Mount Sinai Hospital: Hamid Usman (not pictured)

Mount Sinai Morningside: Alicia Clayton(not pictured)

Mount Sinai Beth Israel: Edgardo Calderon (not pictured)

Mount Sinai South Nassau: Ricardo Ventura

Resilience and Wellness Award

The recipient for this category serves as a role model for resilience and wellness by exemplifying healthy habits and lifestyle, and also helps to promote Mount Sinai resiliency resources and engages others in healthy habits.

Mount Sinai West: Virginia Torres

The Mount Sinai Hospital: Cynthia Mendez

Mount Sinai Morningside: Larissa Leonardo

Mount Sinai South Nassau: David Lee

Emergency Department Clinical Nurse of the Year Award

The recipient for this category is a staff nurse who adheres to nursing standards of practice, and consistently demonstrates exceptional patient care and professionalism. This nurse helps facilitate positive team engagement and high-quality patient outcomes.

Mount Sinai West: Rosemarie Yetman

Mount Sinai Brooklyn: Yelena Shneyder (not pictured)

Mount Sinai Queens: Amparo Sullivan (not pictured)

The Mount Sinai Hospital: Joel Madrid and Nicole Kostakis

Mount Sinai Morningside: Charles Hillman

Mount Sinai Beth Israel: Judy Louie

Mount Sinai South Nassau: Megan Probst

Emergency Department Nurse Leader of the Year Award

The recipient for this category demonstrates excellent leadership skills by serving as a resource through effective communication, working to inspire passion, and promoting professional development. This leader motivates, supports, and creates a high-performance culture for the team.

Mount Sinai West: Nicole Ferrell, Assistant Nurse Manager

Mount Sinai Brooklyn: Lilibeth Pansoy, Clinical Staff Nurse (not pictured)

Mount Sinai Queens: Eileen Brown-Mighty, Nurse Manager (not pictured)

The Mount Sinai Hospital: Olivia Sgambellone, Interim Nurse Manager

Mount Sinai Morningside: Anthony Duncan, Director of Nursing

Mount Sinai Beth Israel: Shari Weisburd, Nurse Manager

Mount Sinai South Nassau: Christopher Brown, Assistant Nurse Manager

Emergency Nursing Team Award 2023

This new category was awarded to The Mount Sinai Hospital Emergency Department Team in recognition of their work and dedication when in August they were selected as a 2023 Lantern Award recipient by the Emergency Nurses Association. The prestigious Lantern Award is a symbol of an emergency department’s commitment to quality, safety, a healthy work environment, and innovation in nursing practice and emergency care. The Mount Sinai Hospital is one of 53 emergency departments in the United States recognized with the Lantern Award.

VF Society Gathers to Celebrate Mentor Valentin Fuster, MD, PhD, and Share Insights in Cardiology

Valentin Fuster, MD, PhD, with physicians in the VF Society, an association of alumni that recently held its 18th Anniversary Dinner.

The Valentin Fuster (VF) Society, a nonprofit alumni association composed  of graduates of the Zena and Michael A. Wiener Cardiovascular Institute, recently held its 18th Anniversary Dinner at the New York Academy of Medicine. One-hundred-twenty alumni attended the event to discuss academic and clinical ideas, reconnect with former colleagues, and express profound appreciation of Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital.

Graduates who have trained with Dr. Fuster created the VF Society to strengthen the bond among alumni and The Mount Sinai Hospital. More than 250 alumni who have trained under Dr. Fuster since 1981 belong to the VF Society. The anniversary dinner is generally held every two years, drawing VF Society members from across the United States and Canada. This year’s gathering was the first since the start of the COVID-19 pandemic.

“Besides being an extraordinary clinician and mentor, Dr.  Fuster takes a genuine interest in each and every fellow’s life. They keep in touch with him and seek his guidance throughout their distinguished careers,” said Martin Goldman, MD, the Dr. Arthur M. and Hilda A. Master Professor of Medicine (Cardiology), Program Director of the Cardiovascular Disease Fellowship Program, and an organizer of the event.

The evening included a panel discussion on the current and future state of cardiology with Dr. Fuster and Eugene Braunwald, MD, the Hersey Professor of Medicine at Harvard Medical School, moderated by Deepak L. Bhatt, MD, MPH, Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine, and Dr. Goldman. Dr. Bhatt said, “It was an extraordinary, once-in-a-lifetime event to see these two cardiovascular legends discuss the key issues in cardiovascular medicine.”

“This celebration was an important opportunity to share scientific information and insights in our field and to strengthen the camaraderie unique to fellows that I have had the privilege to train,” said Dr. Fuster.

Mount Sinai Researcher Launches Three Studies of Alzheimer’s Disease in Asian Americans

Clara Li, PhD, a clinical neuropsychologist and Associate Professor, Psychiatry, at the Icahn School of Medicine at Mount Sinai, has received new grants that will total more than $12 million from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The funding will support three new projects that seek to improve the diagnosis and treatment of Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) in Asian Americans.

Asian Americans are historically under-represented in clinical research on AD/ADRD. As a result, many older adults with Asian ancestry do not receive adequate diagnosis and treatment for mild cognitive impairment (MCI) or AD/ADRD.

Clara Li, PhD

“Chinese is the third-most-spoken language in the United States after English and Spanish, yet we don’t have many of these tools available,” Dr. Li explains. She’s hoping to change that, with three new studies launched in 2023.

Adapting Assessments for Alzheimer’s: Chinese Translation and Cultural Adaptation

In one of the studies, a five-year effort, Dr. Li will develop assessment tools that are linguistically and culturally adapted for older adults who speak Cantonese or Mandarin, with the hope to extend it to other Asian languages in the future.

Researchers rely on assessment tools from the National Alzheimer’s Coordinating Center Uniform Data Set (NACC UDS) to identify research participants with cognitive impairment or AD/ADRD. But those tests were developed for English speakers and Western cultures.

“I’ve seen many Asian American patients who try to take the English tests because a Chinese version isn’t available, and the language is a barrier,” Dr. Li says. “Sometimes a test would suggest cognitive impairment, but when I would translate the test myself into Chinese, the patient would score in the normal range.”

Language isn’t the only barrier. Cultural differences also make the test confusing for many Asian American patients. When asked to identify an image of a witch on the standard test, for instance, some of Dr. Li’s patients said “janitor” or “cleaner”—a common error because witches aren’t typically depicted with brooms in Chinese culture.

The lack of adequate tests hampers diagnosis and treatment, and also affects research seeking to better understand AD/ADRD in Asian Americans.

“Because we can’t enroll patients unless they can take the tests in English, many are excluded from studies. As a result, Asian Americans make up less than 2 percent of the participants in U.S. clinical trials,” Dr. Li explains. “If we want to increase diversity in research, we need to adapt these materials for Chinese speakers and eventually other Asian languages.”

A Research Infrastructure for Alzheimer’s Disease in Asian Americans

In the second study, Dr. Li will develop a research infrastructure and tools for studying AD/ADRD in older Asian Americans. She and her colleagues will develop questionnaires to fully characterize Asian American participants, including social determinants of health and any environmental or lifestyle factors that could increase or decrease their risk of developing AD/ADRD.

This five-year study will also investigate blood samples from Asian American participants to determine whether there may be novel biomarkers in this population, and whether known biomarkers are relevant to people from Asian backgrounds.

“Amyloid and tau are well known as biomarkers associated with Alzheimer’s disease, but those biomarkers were developed primarily from Caucasian samples. Therefore, the generalization of these findings in Asian Americans is not always clear, including criteria for amyloid and tau burden to establish AD/ADRD risk,” she says. “There may be different thresholds for those biomarkers in different populations.”

Support for Mild Cognitive Impairment

Dr. Li’s third newly funded project is a two-year pilot clinical trial. She and her colleagues will adapt the Memory Support System (MSS) for use in Chinese Americans who speak Cantonese or Mandarin. The MSS is a memory calendar training program to help older adults with MCI organize and remember their daily activities. The system is a component of the Healthy Action to Benefit Independence & ThinkingÒ (HABIT) Program, an evidence-based intervention that provides lifestyle and behavioral treatments for older adults with MCI.

“I see patients with MCI who want to do something to prevent the development of dementia, but if they can’t speak fluent English, they aren’t able to participate in clinical trials,” Dr. Li says. “We hope that by adapting this program, we can offer Chinese American older adults with MCI an opportunity to participate in a trial that seeks to improve memory and function, as well as their mood and quality of life.”

Alzheimer’s Disease Research at Mount Sinai

In addition to the three new studies Dr. Li has launched this year, she is leading two clinical trials at the Alzheimer’s Disease Research Center at Icahn Mount Sinai and is the site Principal Investigator for the Asian Cohort for Alzheimer’s Disease (ACAD) study, a multisite project to analyze genetic data to identify risk variants for Alzheimer’s disease in Asian Americans and Asian Canadians.

Through these projects, she hopes to improve research participation, diagnosis, and treatment related to patients of Asian ancestry—an effort that is long overdue, she says.

“There’s a lot of work that needs to be done. In addition to research inequities, there aren’t enough bilingual physicians outside the community, which often makes it difficult for Asian American older adults to receive integrated specialty care, leading to delayed diagnosis and treatment for AD/ADRD,” she adds.

Mount Sinai serves a diverse patient population and is committed to improving care by addressing bias and racism. Icahn Mount Sinai and Mount Sinai Health System created the Center for Asian Equity and Professional Development to address the equity and professional development challenges faced by Asian Americans and Pacific Islanders.

Mount Sinai Receives Five-Year Grant to Support First-of-Its-Kind Translational Science Program for Nurses

Mount Sinai’s Center for Nursing Research and Innovation (CNRI) is developing a first-of-its-kind program that supports Doctor of Nursing Practice (DNP) students from underrepresented minority communities and disadvantaged backgrounds to become experts in translating research into clinical practice. The program’s development is being funded by a five-year grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health.

“We are so excited to have achieved this significant milestone,” says Kimberly Souffront, PhD, RN, FNP-BC, Associate Director of CNRI. “This initiative is a significant step toward fostering diversity, equity, and inclusion in our research and health care communities. It not only creates opportunities for underrepresented DNP students but also underscores the vital role of diverse perspectives in advancing translational research and eliminating health disparities.”

The 12-week summer program, Translational Research and Implementation Science for Nurses (TRAIN) at Mount Sinai, will provide DNP students with impactful translational research mentorship within the clinical setting. TRAIN will deliver collaborative, multidisciplinary, multispecialty classroom education and hands-on research experiences mentored by experts in fields of health disparities, hypertension, and other clinical topics central to the NHLBI mission. Students who meet the criteria and are enrolled in any accredited DNP program are eligible to apply.

“DNP-prepared nurses from diverse backgrounds are uniquely and exceptionally qualified to lead translational research for advancing health equity,” says Bevin Cohen, PhD, MS, MPH, RN, CNRI Director.

The inaugural TRAIN program will run from Tuesday, May 28, through Friday, August 16, 2024, with participants devoting 30 hours per week to program activities. A generous stipend is provided to offset the financial impact of professional development in this critical field.

“Having nurses who are prepared to participate as full partners in the research enterprise is critically important,” says Lynne Richardson, MD, FACEP, Founding Co-Director of the Institute for Health Equity Research at Mount Sinai and Endowed Professor of Emergency Medicine and Health Equity Science, Icahn School of Medicine at Mount Sinai. “TRAIN will build the pool of doctoral nurses who are engaged in translational research and implementation science.”

Those interested in learning more about the TRAIN program can email questions to TRAIN@mountsinai.org.

Pin It on Pinterest